Tevogen Regains Nasdaq Compliance with Market Requirements
Tevogen Inc. received official notice resolving both Nasdaq noncompliance issues on September 29, 2026, ensuring continued listing on the Global Market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed